Sign in

CIK 0000860730

  • Large accelerated filer

HCA Healthcare, Inc.

Sign in to watch
Ticker
HCA
Exchange
NYSE
Industry
Services-General Medical & Surgical Hospitals, NEC
FY end
Dec 31
Entity type
Operating
EIN
273865930
Phone
+1 615-344-9551
Business address
ONE PARK PLZ, NASHVILLE, TN, 37203
Former names
HCA Holdings, Inc., HCA INC/TN, HCA THE HEALTHCARE CO, HCA-THE HEALTHCARE CO, COLUMBIA HCA HEALTHCARE CORP, COLUMBIA HCA HEALTHCARE CORP/, COLUMBIA HEALTHCARE CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$18,251,400
in 3 filings

Net −$18,251,400. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-10 Cuffe Michael S. EVP and Chief Clinical Officer Grant or award +9,628 35,580.9
2026-02-10 Cuffe Michael S. EVP and Chief Clinical Officer Shares withheld for taxes −3,501 $502.05 $1.8M 32,079.9
2026-02-03 Cuffe Michael S. EVP and Chief Clinical Officer Sale −1,500 $498.09 $747K 30,002.9
2026-02-03 Cuffe Michael S. EVP and Chief Clinical Officer Gift −4,050 25,952.9
2026-01-29 Cuffe Michael S. EVP and Chief Clinical Officer Grant or award · Stock Appreciation Right +8,067 8,067
2025-09-08 Cuffe Michael S. EVP and Chief Clinical Officer Sale 10b5-1 −3,836 $418.84 $1.6M 31,502.9
2025-09-04 Cuffe Michael S. EVP and Chief Clinical Officer Option exercise 10b5-1 +10,920 $173.12 $1.9M 42,422.9
2025-09-04 Cuffe Michael S. EVP and Chief Clinical Officer Shares withheld for taxes 10b5-1 −7,084 $411.59 $2.9M 35,338.9
2025-09-04 Cuffe Michael S. EVP and Chief Clinical Officer Option exercise · Stock Appreciation Right 10b5-1 −10,920 10,000
2025-02-13 Cuffe Michael S. EVP and Chief Clinical Officer Grant or award +2,330 32,008.21
2025-02-13 Cuffe Michael S. EVP and Chief Clinical Officer Shares withheld for taxes −583 $321.92 $188K 31,425.21
2025-01-28 Cuffe Michael S. EVP and Chief Clinical Officer Grant or award · Stock Appreciation Right +11,171 11,171
2024-09-12 Cuffe Michael S. EVP and Chief Clinical Officer Sale 10b5-1 −8,358 $385.42 $3.2M 29,678.21
2024-09-10 Cuffe Michael S. EVP and Chief Clinical Officer Option exercise 10b5-1 +22,080 $145.24 $3.2M 51,758.21
2024-09-10 Cuffe Michael S. EVP and Chief Clinical Officer Shares withheld for taxes 10b5-1 −13,722 $386.43 $5.3M 38,036.21
2024-09-10 Cuffe Michael S. EVP and Chief Clinical Officer Option exercise · Stock Appreciation Right 10b5-1 −22,080 0
2024-05-09 Cuffe Michael S. EVP and Chief Clinical Officer Sale −6,311 $316.88 $2.0M 29,623.97
2024-05-08 Cuffe Michael S. EVP and Chief Clinical Officer Gift −4,500 35,934.97
2024-05-07 Cuffe Michael S. EVP and Chief Clinical Officer Option exercise +18,660 $139.06 $2.6M 52,783.97
2024-05-07 Cuffe Michael S. EVP and Chief Clinical Officer Shares withheld for taxes −12,349 $314.45 $3.9M 40,434.97

Page 1 of 5 · 86 trades